MGX
Price:
$1.79
Market Cap:
$67.21M
Metagenomi, Inc., a gene editing biotechnology company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. It has a strategic collaboration and license agreement with ModernaTX, Inc. focusing on new genome editing system for in vivo human therapeutic applications; a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited T-cell recepto...[Read more]
Industry
Biotechnology
IPO Date
2006-04-06
Stock Exchange
NASDAQ
Ticker
MGX
According to Metagenomi, Inc. Common Stock’s latest financial reports and current stock price. The company's current PE Ratio is -0.66. This represents a change of -28.39% compared to the average of -0.92 of the last 4 quarters.
The mean historical PE Ratio of Metagenomi, Inc. Common Stock over the last ten years is -4.78. The current -0.66 PE Ratio has changed 1.28% with respect to the historical average. Over the past ten years (40 quarters), MGX's PE Ratio was at its highest in in the March 2025 quarter at -0.50. The PE Ratio was at its lowest in in the September 2022 quarter at -9.30.
Average
-4.78
Median
-4.26
Minimum
-8.86
Maximum
-1.73
Discovering the peaks and valleys of Metagenomi, Inc. Common Stock PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 210.83%
Maximum Annual PE Ratio = -1.73
Minimum Annual Increase = -69.43%
Minimum Annual PE Ratio = -8.86
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.73 | -69.43% |
| 2023 | -5.66 | -36.13% |
| 2022 | -8.86 | 210.83% |
The current PE Ratio of Metagenomi, Inc. Common Stock (MGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.42
5-year avg
-4.78
10-year avg
-4.78
Metagenomi, Inc. Common Stock’s PE Ratio is greater than Precision BioSciences, Inc. (-0.71), greater than aTyr Pharma, Inc. (-1.07), less than Adverum Biotechnologies, Inc. (-0.48), greater than Artiva Biotherapeutics, Inc. (-1.28), less than Sutro Biopharma, Inc. (-0.37), greater than Quince Therapeutics, Inc. (-3.43), greater than InflaRx N.V. (-1.41), greater than Kalaris Therapeutics Inc (-2.14), greater than Connect Biopharma Holdings Limited (-3.90), less than ALX Oncology Holdings Inc. (-0.63),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.71 | $66.54M | |
| -1.07 | $81.11M | |
| -0.48 | $92.06M | |
| -1.28 | $92.66M | |
| -0.37 | $79.86M | |
| -3.43 | $200.45M | |
| -1.41 | $74.52M | |
| -2.14 | $110.72M | |
| -3.90 | $141.98M | |
| -0.63 | $74.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Metagenomi, Inc. Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Metagenomi, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Metagenomi, Inc. Common Stock's PE Ratio?
How is the PE Ratio calculated for Metagenomi, Inc. Common Stock (MGX)?
What is the highest PE Ratio for Metagenomi, Inc. Common Stock (MGX)?
What is the 3-year average PE Ratio for Metagenomi, Inc. Common Stock (MGX)?
What is the 5-year average PE Ratio for Metagenomi, Inc. Common Stock (MGX)?
How does the current PE Ratio for Metagenomi, Inc. Common Stock (MGX) compare to its historical average?